TrialPediatric blood & cancer2024

Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.

Jonathan Metts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.